ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) - DISPOSITION IN MAN

被引：230

作者：

ULM, EH

HICHENS, M

GOMEZ, HJ

TILL, AE

HAND, E

VASSIL, TC

BIOLLAZ, J

BRUNNER, HR

SCHELLING, JL

机构：

[1] MERCK SHARP & DOHME,RES LABS,RAHWAY,NJ 07065

[2] CHU LAUSANNE,DEPT MED,CH-1011 LAUSANNE,SWITZERLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1982年 / 14卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1982.tb01991.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：357 / 362

页数：6

共 15 条

[1] 3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J].

BIOLLAZ, J ;

BURNIER, M ;

TURINI, GA ;

BRUNNER, DB ;

PORCHET, M ;

GOMEZ, HJ ;

JONES, KH ;

FERBER, F ;

ABRAMS, WB ;

GAVRAS, H ;

BRUNNER, HR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :665-670

[2] ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].

BIOLLAZ, J ;

SCHELLING, JL ;

COMBES, BJD ;

BRUNNER, DB ;

DESPONDS, G ;

BRUNNER, HR ;

ULM, EH ;

HICHENS, M ;

GOMEZ, HJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368

[3] EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].

BRUNNER, DB ;

DESPONDS, G ;

BIOLLAZ, J ;

KELLER, I ;

FERBER, F ;

GAVRAS, H ;

BRUNNER, HR ;

SCHELLING, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467

[4]

GAVRAS H, 1981, LANCET, V2, P543

[5]

GROSS DM, 1981, J PHARMACOL EXP THER, V216, P552

[6]

HICHENS M, 1981, Ligand Quarterly, V4, P43

[7]

HOROWITZ ZP, 1981, ANGIOTENSINS CONVERT

[8] EFFECT OF CAPTOPRIL ON PROTEINS AND PEPTIDE-HORMONES [J].

IGIC, RP ;

GAFFORD, JT ;

ERDOS, EG .

BIOCHEMICAL PHARMACOLOGY, 1981, 30 (06) :683-685

[9]

IKEDA T, 1981, CHEM PHARM BULL, V29, P1416

[10] DISPOSITION OF CAPTOPRIL IN NORMAL SUBJECTS [J].

KRIPALANI, KJ ;

MCKINSTRY, DN ;

SINGHVI, SM ;

WILLARD, DA ;

VUKOVICH, RA ;

MIGDALOF, BH .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) :636-641

← 1 2 →